Page last updated: 2024-09-03

n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Hypertension, Pulmonary

n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate has been researched along with Hypertension, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambino, A; Thomas, BJ; Wanstall, JC1

Other Studies

1 other study(ies) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Hypertension, Pulmonary

ArticleYear
KRN2391: dual action on rat pulmonary artery and no loss of potency in pulmonary hypertension.
    Clinical and experimental pharmacology & physiology, 2000, Volume: 27, Issue:4

    Topics: Adenosine Triphosphate; Animals; Cromakalim; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Hypoglycemic Agents; In Vitro Techniques; Infant, Newborn; Male; Methylene Blue; Molsidomine; Nitric Oxide Donors; Potassium Channels; Pulmonary Artery; Pyridines; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents

2000